FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to anthranilic acid amides of the formula (I): wherein R1 means hydrogen atom or (lower)-alkyl; R2 means hydrogen atom or (lower)-alkyl; R3 means perfluoro-(lower)-alkyl; X means oxygen atom or sulfur atom, or to its N-oxide or tautomer, to salts of such anthranilic acid amides, their N-oxides or their tautomers. Compounds of the formula (I) possess inhibitory activity with respect to tyrosine kinase VEGF receptors and can be used in treatment of neoplasm, retinopathy or age degeneration resulting to appearance of spots in retina in humans or mammals. Also, invention relates to using anthranilic acid amide of the formula (I) for preparing a pharmaceutical drug possessing above said activity, to a method for treatment of neoplasm disease, a pharmaceutical drug and a method for synthesis of anthranilic acid amide of the formula (I).
EFFECT: improved method of synthesis, valuable medicinal properties of compounds and pharmaceutical drug.
9 cl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
ANTHRANILIC ACID AMIDES AND THEIR USING IN PHARMACEUTICALS | 2002 |
|
RU2315756C2 |
ANTHRANILIC ACID AND THIOANTHRANILIC ACID N-ARYLAMIDES | 1999 |
|
RU2286338C2 |
DERIVATIVES OF 2-AMINONICOTINE AMIDE AND THEIR USING AS INHIBITORS OF TYROSINE KINASE VEGF RECEPTORS | 2001 |
|
RU2296124C2 |
TYROSINE KINASE INHIBITORS | 2008 |
|
RU2445309C2 |
NOVEL PYRIMIDINE AMIDE DERIVATIVES AND USE THEREOF | 2003 |
|
RU2378267C2 |
NEW ANTHRANILAMIDOPYRIDINEUREAS AS VEGF RECEPTOR KINASE INHIBITORS | 2005 |
|
RU2415850C2 |
COMBINATION, INCLUDING A) PYRIMIDYLAMINOBENZAMIDE AND B) KINASE Thr315lle INHIBITOR | 2007 |
|
RU2481840C2 |
APPLICATION OF PYRIMIDYLAMINOBENZAMIDES FOR TREATMENT OF DISEASES SENSITIVE TO MODULATION OF KINASE Tie-2 ACTIVITY | 2006 |
|
RU2404776C2 |
PYRIMIDYLAMINOBENZAMIDE DERIVATIVES FOR NEUROFIBROMATOSIS | 2006 |
|
RU2450814C2 |
COMBINATIONS CONTAININS Bcr-Abl/c-Kit/PDGF-RTK INHIBITORS FOR TREATING CANCER | 2007 |
|
RU2452492C2 |
Authors
Dates
2008-03-10—Published
2002-11-07—Filed